Back to Search
Start Over
A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia: The ASPEN study
- Authors :
- UMC Utrecht Holding
MS Hematologie
Infection & Immunity
Regenerative Medicine and Stem Cells
Cancer
Tam, Constantine S
Opat, Stephen
D'Sa, Shirley
Jurczak, Wojciech
Lee, Hui-Peng
Cull, Gavin
Owen, Roger G
Marlton, Paula
Wahlin, Björn Engelbrekt
Garcia-Sanz, Ramon
McCarthy, Helen
Mulligan, Stephen
Tedeschi, Alessandra
Castillo, Jorge
Czyz, Jaroslaw
Fernández de Larrea, Carlos
Belada, David
Libby, Edward
Matous, Jeffrey V
Motta, Marina
Siddiqi, Tanya
Tani, Monica
Trneny, Marek
Minnema, Monique C
Buske, Christian
Leblond, Veronique
Chan, Wai Y
Schneider, Jingjing Yan
Ro, Sunhee
Cohen, Aileen
Huang, Jane
Dimopoulos, Meletios A
UMC Utrecht Holding
MS Hematologie
Infection & Immunity
Regenerative Medicine and Stem Cells
Cancer
Tam, Constantine S
Opat, Stephen
D'Sa, Shirley
Jurczak, Wojciech
Lee, Hui-Peng
Cull, Gavin
Owen, Roger G
Marlton, Paula
Wahlin, Björn Engelbrekt
Garcia-Sanz, Ramon
McCarthy, Helen
Mulligan, Stephen
Tedeschi, Alessandra
Castillo, Jorge
Czyz, Jaroslaw
Fernández de Larrea, Carlos
Belada, David
Libby, Edward
Matous, Jeffrey V
Motta, Marina
Siddiqi, Tanya
Tani, Monica
Trneny, Marek
Minnema, Monique C
Buske, Christian
Leblond, Veronique
Chan, Wai Y
Schneider, Jingjing Yan
Ro, Sunhee
Cohen, Aileen
Huang, Jane
Dimopoulos, Meletios A
- Publication Year :
- 2020
Details
- Database :
- OAIster
- Notes :
- English
- Publication Type :
- Electronic Resource
- Accession number :
- edsoai.on1432112881
- Document Type :
- Electronic Resource